Of Hearts and Giants: Biggest Protein Helps Study Cardiac Disease
News Jun 28, 2018
Models for alternative splicing regulation of TTN pre-mRNAs by wild-type (left) and mutant (right) RBM20. Credit: TMD
The largest known protein, the appropriately named titin after the Titan giants of Greek mythology, is a molecular spring found in cardiac muscle. It provides structural support and maintains tension during muscle stretching. Mutations in the titin gene, and in the gene encoding its regulatory protein RBM20, cause dilated cardiomyopathy (DCM), in which the left ventricle of the heart is enlarged and weakened, so cannot pump blood around the body efficiently.
The RBM20 protein is divided into domains that have remained unchanged throughout evolution, thus sharing identical sequences among different species. Such regions are usually functionally important, but the role of the fully conserved 5-residue RSRSP stretch within an RS-rich region, full of arginine (R) and serine (S) amino acids, had not been investigated. However, this stretch is the site of many different mutations in DCM patients, a mutation “hotspot,” so it was ripe for exploration.
An international team of researchers led by Tokyo Medical and Dental University (TMDU) investigated the RSRSP stretch and showed it to be essential for nuclear localization of the RBM20 protein. Chemical modification of part of this stretch was also found to be important in the role of RBM20 as a titin regulator. The study was reported in Scientific Reports.
RBM20 controls a step in gene expression of the titin gene known as splicing, whereby introns are removed to leave the protein-coding exons behind as messenger RNA. Intron–exon processing can exclude certain exons, resulting in two major versions of titin that have distinct effects on normal cardiac function as well as cardiac dysfunction leading to DCM progression.
“We found mutations in DCM patients and examined the effect of mutations, especially those in the RSRSP stretch of RBM20,” study authors Hidehito Kuroyanagi and Akinori Kimura say. “Wild-type RBM20 was localized in the nucleus where splicing occurs, whereas the mutations in the RSRSP stretch prevented the protein from localizing there and carrying out its function.” However, the mutations had no effect on the actual role of RBM20 in splicing per se.
Mice genetically engineered to carry an RBM20 mutation of the RSRSP stretch seen in DCM patients were unable to express the smaller version of titin like the patients because of the effect of the mutation on the RBM20 function as a splicing regulator. These mice will prove useful as a DCM disease model for future in vivo work.
The team then showed that amino acids in the RSRSP stretch undergo phosphorylation, which is the enzyme-controlled addition of a phosphate group that is often involved in protein activation. “For the first time, we found that two serine residues in the RSRSP stretch are constitutively phosphorylated,” corresponding author Hidehito Kuroyanagi explains. “Moreover, the simultaneous phosphorylation of both serine residues was essential for the nuclear localization of RBM20.”
This article has been republished from materials provided by Tokyo Medical and Dental University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Reference: Murayama, R., Kimura-Asami, M., Togo-Ohno, M., Yamasaki-Kato, Y., Naruse, T. K., Yamamoto, T., … Kuroyanagi, H. (2018). Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization. Scientific Reports, 8(1), 8970. https://doi.org/10.1038/s41598-018-26624-w
Synthetic Material That Detects Enzymatic ActivityNews
Scientists integrate protein and polymer building blocks to create stimulus-responsive systemsREAD MORE
Hidden Signals in RNAs Regulate Protein SynthesisNews
Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019